papillary thyroid carcinoma
Conditions
Interventions
experience group :Selenium yeast tablets + thyroid hormone
control group:thyroid hormone
Sponsors
The Second Affiliated Hospital of Harbin Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) All patients completed the operation in the same medical group; (2) PTC was confirmed by intraoperative and postoperative pathology, and Hashimoto's thyroiditis was complicated by postoperative pathology; (3) The level of TGAb before and after operation was higher than normal (chemiluminescence, the normal value range was 0-4.11 IU / ml). (4) All patients were routinely treated with postoperative thyroid hormone replacement therapy according to the 2015 ATA thyroid cancer treatment guidelines and were able to follow up on time.
Exclusion criteria
Exclusion criteria: (1) The patient had a history of thyroid disease or related drugs. (2) Have a positive history of Graves' ophthalmopathy (go) and thyrotropin receptor antibody (TRAb). (3) Patients were treated with I131 after operation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tg;TgAb; | — |
Secondary
| Measure | Time frame |
|---|---|
| Operation mode;Tumor diameter;Multiple lesions;Extraglandular invasion;Number of lymph node dissections;Number of lymph node metastases; | — |
Countries
china
Contacts
Public ContactShi Chenlei
Outcome results
None listed